All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Cervical Intraepithelial Neoplasia-9485042
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 9485042 A647G
E7
E7
Cervical Intraepithelial Neoplasia
G
L
View
2 9485042 G666A
E7
E7
Cervical Intraepithelial Neoplasia
G
L
View
3 9485042 N29S
E7
E7
Cervical Intraepithelial Neoplasia
G
L
View
4 9485042 A131G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
5 9485042 A135C
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
6 9485042 A276G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
7 9485042 A282T
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
8 9485042 A403G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
9 9485042 A61G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
10 9485042 C110T
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
11 9485042 C143G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
12 9485042 C285G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
13 9485042 G132T
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
14 9485042 I27T
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
15 9485042 K11T
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
16 9485042 N58S
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
17 9485042 Q14D
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
18 9485042 Q3E
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
19 9485042 R10I
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
20 9485042 T109G
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
21 9485042 T146C
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
22 9485042 T183C
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
23 9485042 Y60F
E6
E6
Cervical Intraepithelial Neoplasia
G
L
View
24 9485042 A822G
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
25 9485042 T732C
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
26 9485042 T789C
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
27 9485042 T795G
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
28 9485042 A289G
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
29 9485042 A532G
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
30 9485042 C256T
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
31 9485042 C335T
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
32 9485042 G145T
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
33 9485042 H78Y
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
34 9485042 L83V
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
35 9485042 Q14H
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
36 9485042 T286A
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
37 9485042 T350G
E6
E6
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.